Form 4: Aramark Director Stephen Sadove Receives Stock Grant

Aramark Director Stephen I. Sadove was granted 7,751 deferred stock units, valued at $38.06 per unit, vesting based on continued service.

Summary

• Stephen I. Sadove, a Director of Aramark (ARMK), acquired 7,751 shares of Common Stock.
• The transaction occurred on February 3, 2026, at a price of $38.06 per share.
• This acquisition represents a grant of deferred stock units.
• These units will vest on the day prior to the first annual stockholders' meeting of Aramark occurring after the grant date, contingent on continued service.
• Upon vesting, the units will be settled in shares of common stock on the first day of the seventh month after Mr. Sadove's departure from the board.
• Following this transaction, Mr. Sadove beneficially owns 102,049.114 shares directly and 15,000 shares indirectly through a Trust.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It's a routine compensation grant, aligning director interests with shareholders, but not indicative of significant operational changes or new strategic initiatives.

Positives

• Director Stephen I. Sadove received a grant of 7,751 deferred stock units, aligning his interests with long-term shareholder value.
• The grant price of $38.06 per unit indicates a specific valuation at the time of the grant.

Risks

• The vesting of the deferred stock units is subject to continued service, meaning Mr. Sadove must remain on the board until the vesting date to receive the shares.

Future Outlook

The deferred stock units are set to vest on the day prior to the first annual stockholders' meeting following the grant date, contingent on continued service. If vested, settlement in common stock will occur on the first day of the seventh month after the director's departure from the board.

Industry Context

StockSavvy.ai notes that routine grants of deferred stock units to directors are a common form of executive and director compensation across various industries, designed to align long-term interests with company performance and shareholder value. This specific grant to an Aramark director is consistent with typical corporate governance practices for public companies.

Comparison to Industry Standards

• Director compensation through deferred stock units is a standard practice in the U.S. market, comparable to companies like Sodexo or Compass Group in the food services industry, which also utilize equity-based incentives for their board members.
• The vesting schedule tied to continued service and future settlement upon departure is a common mechanism to ensure long-term commitment and retention, aligning with best practices observed in S&P 500 companies.

Related Party Transactions

• The grant of deferred stock units to Director Stephen I. Sadove constitutes a related party transaction, as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with long-term shareholder value, potentially encouraging decisions that benefit the company's stock performance.
• Employees: No direct impact on employees is indicated by this filing.
• Management: No direct impact on management beyond the reporting director is indicated.

Next Steps

• Vesting of the 7,751 deferred stock units on the day prior to the first annual stockholders' meeting of Aramark occurring after the grant date, subject to continued service.
• Settlement of vested units in shares of common stock on the first day of the seventh month after the director's departure from the board.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of deferred stock units to a director as part of their compensation. While it aligns the director's interests with the company's long-term performance, it does not provide new material information about Aramark's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a "hold" recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Aramark, ARMK, Stephen Sadove, Form 4, Insider Transaction, Stock Grant, Deferred Stock Units, Director Compensation, Beneficial Ownership